{"id":"W2990283038","doi":"10.1007/s12325-019-01145-8","title":"Long-Term Safety of Adalimumab in 29,967 Adult Patients From Global Clinical Trials Across Multiple Indications: An Updated Analysis","year":2019,"lang":"en","type":"article","venue":"Advances in Therapy","topic":"Hidradenitis Suppurativa and Treatments","field":"Medicine","cited_by":95,"is_retracted":false,"has_abstract":true,"ca_institutions":"University of Calgary","funders":"AbbVie; Celgene; Amgen; Pfizer; Eli Lilly and Company; Bristol-Myers Squibb","keywords":"Medicine; Adalimumab; Clinical trial; Rheumatology; Internal medicine; Term (time); Intensive care medicine; Safety profile; Adverse effect; Medical physics; Rheumatoid arthritis","routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":false,"invisible_to_affiliation_only":false},"retraction":null,"screen":null,"direct_labels":[],"prediction":{"model_version":"metacan-v3-hybrid-931329e0061c","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.02740313,0.0009038838,0.003863523,0.002426029,0.0003247914,0.002208465,0.0007610951,0.0008604688,0.001835528],"category_scores_gemma":[0.02236628,0.0005568519,0.005722802,0.004658644,0.0005028481,0.001476978,0.001008027,0.0009992342,0.0003430468],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.0007442069,"about_ca_system_score_gemma":0.001050402,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.0005691411,"about_ca_topic_score_gemma":0.001154506,"domain_scores_codex":[0.9821579,0.006522475,0.00516478,0.002264363,0.003445092,0.0004453064],"domain_scores_gemma":[0.9645136,0.01644328,0.01342716,0.0021707,0.002763765,0.0006816156],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"observational","study_design_gemma":"meta_analysis","study_design_scores_codex":[0.03148866,0.0002275396,0.5990624,0.02543802,0.1165364,0.0007748672,0.0005711908,0.002658868,0.003526949,0.0002737538,0.006563009,0.2128783],"study_design_scores_gemma":[0.007583716,0.005480071,0.8615445,0.003279343,0.09385922,0.002348929,0.0002002478,0.0009719657,0.001509368,0.0004066231,0.02271224,0.0001038259],"study_design_candidate":"meta_analysis","study_design_consensus":null,"genre_codex":"empirical","genre_gemma":"empirical","genre_scores_codex":[0.5588422,0.4130802,0.00306462,0.0008129791,0.0001261823,0.000922675,0.01876724,0.0001236986,0.004260161],"genre_scores_gemma":[0.9311554,0.04996463,0.002212366,0.0009633533,0.0002791414,0.001043898,0.01383719,0.0000662505,0.0004777922],"genre_candidate":"empirical","genre_consensus":"empirical","teacher_disagreement_score":0.02740313,"threshold_uncertainty_score":0.1449233,"prediction_status":"machine_predicted_unvalidated"},"machine_scores":{"provisional":true,"baseline":true,"maturity_gate_passed":false,"score_opus":0.04198891975818134,"score_gpt":0.4470875412390481,"score_spread":0.4050986214808668,"validation_status":"score_only:v0-immature-baseline","note":"Baseline scores from an immature model (maturity gate not passed). Scores rank; they never assert a category."}}